Napp launches pegfilgrastim biosimilar in the UK
Napp Pharmaceuticals has launched Pelmeg – a pegfilgrastim biosimilar – across the UK.
Read Moreby Anna Smith | Mar 4, 2019 | News | 0
Napp Pharmaceuticals has launched Pelmeg – a pegfilgrastim biosimilar – across the UK.
Read Moreby Selina McKee | Sep 10, 2018 | News | 0
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma.
Read Moreby Selina McKee | May 4, 2018 | News | 0
Mundipharma announced that its network of companies has kicked off the rollout of Celltrion’s Herceptin biosimilar Herzuma in Europe.
Read Moreby Selina McKee | Mar 20, 2018 | News | 0
Napp Pharmaceuticals has secured itself exclusive UK distribution rights to Celltrion Healthcare’s Herceptin biosimilar Herzuma.
Read Moreby Selina McKee | Aug 5, 2016 | News | 0
Novartis’ generics arm Sandoz is launching its long-acting buprenophine patch Reletrans in the UK following victory in a patent battle with Napp Pharmaceuticals.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
